Compared to the VIRAL-HCC group, MASLD-HCC patients exhibited lower mean hemoglobin, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, but higher platelet counts. Here, GPT is linked to hepatocellular carcinoma.